Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3

Annals of the Rheumatic Diseases

Volumn 70, Issue 9, 2011, Pages 1655-1663

  Chen, Yu Hsuan ^a   Hsieh, Song Chou ^b   Chen, Wei Yu ^c   Li, Ko Jen ^b   Wu, Cheng Han ^b   Wu, Po Chang ^b   Tsai, Chang Youh ^d   Yu, Chia Li ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; MESSENGER RNA; REGULATOR PROTEIN; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 4; SUPPRESSOR OF CYTOKINE SIGNALING 5; SUPPRESSOR OF CYTOKINE SIGNALING 6; SUPPRESSOR OF CYTOKINE SIGNALING 7; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; URATE;

ACUTE DISEASE; ANIMAL CELL; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GOUT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL FLUID LEVEL; SYNOVIUM; UPREGULATION;

ACUTE DISEASE; ANIMALS; ARTHRITIS, GOUTY; CELLS, CULTURED; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MACROPHAGES; MICE; OSTEOARTHRITIS, KNEE; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION, SPONTANEOUS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TRANSFORMING GROWTH FACTOR BETA1; URIC ACID;

EID: 80955177526     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.145821     Document Type: Article

References (41)

1. Martinon F, Glimcher LH. Gout: new insights into an old disease. J Clin Invest 2006;116:2073-5. (Pubitemid 44162311)
2. Haskard DO, Landis RC. Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response. Arthritis Res 2002;4(Suppl 3):S91-7.
3. Scott P, Ma H, Viriyakosol S, et al. E ngagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 2006;177:6370-8. (Pubitemid 44642121)
4. Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther 2006;8 (Suppl 1) :S3.
5. Poor G, Mituszova M. Crystal-related arthropathies. In:Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, (eds). Rheumatology. 3rd edition. Vol 2. Mosby:London, 2003;1891-964.
6. Ortiz-Bravo E, Sieck MS, Schumacher HR Jr. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993;36:1274-85. (Pubitemid 23303118)
7. LiotéF, Prudhommeaux F, Schiltz C, et al. Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 1996;39:1192-8. (Pubitemid 26240234)
8. Falasca GF, Ramachandrula A, Kelley KA, et al. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 1993;36:105-16. (Pubitemid 23048686)
9. DiGiovine FS, Malvista SE, Nuki G, et al. Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial fibroblast mitogenesis by urate crystalinduced IL-1. J Immunol 1987;138:3213-18. (Pubitemid 17071894)
10. Guerne PA, Zuraw BL, Vaughan JH, et al. S ynovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-92. (Pubitemid 19061181)
11. Guerne PA, Terkeltaub R, Zuraw B, et al. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989;32:1443-52. (Pubitemid 20003912)
12. Terkeltaub R, Zachariae C, Santoro D, et al. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
13. Yagnik DR, Hillyer P, Marshall D, et al. Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 2000;43:1779-89.
14. Yagnik DR, Evans BJ, Florey O, et al. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004;50:2273-80. (Pubitemid 38924406)
15. Landis RC, Yagnik DR, Florey O, et al. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002;46:3026-33. (Pubitemid 35315897)
16. Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890-8. (Pubitemid 28096086)
17. Yoshimura A, Nishinakamura H, Matsumura Y, et al. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 2005;7:100-10. (Pubitemid 40775170)
18. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 2008;19:414-22.
19. Wallace SL, Robinson H, Masi AT, et al. P reliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
20. Altman R, Asch E, Bloch D, et al. D evelopment of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
22. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8. (Pubitemid 14134775)
23. Seegmiller JE, Howell RR, Malawista SE. The inflammatory reaction to sodium urate. JAMA 1962;180:469-75.
24. Kinjyo I, Inoue H, Hamano S, et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 2006;203:1021-31.
25. Van Zee KJ, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-9.
26. Yoshimura A, Ohkubo T, Kiguchi T, et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995;14:2816-26.
27. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000;18:143-64. (Pubitemid 30365377)
28. Chen L, Hsieh MS, Ho HC, et al. Stimulation of inducible nitric oxide synthase by monosodium urate crystals in macrophages and expression of iNOS in gouty arthritis. Nitric Oxide 2004;11:228-36. (Pubitemid 39582753)
29. Benkhart EM, Siedlar M, Wedel A, et al. Role of Stat3 in lipopolysaccharideinduced IL-10 gene expression. J Immunol 2000;165:1612-17. (Pubitemid 30604599)
30. Fava R, Olsen N, Keski-Oja J, et al. A ctive and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 1989;169:291-6. (Pubitemid 19035558)
31. Murakami Y, Akahoshi T, Kawai S, et al. Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches. Arthritis Rheum 2002;46:2504-13.
32. Gatanaga T, Hwang CD, Kohr W, et al. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci USA 1990;87:8781-4. (Pubitemid 120007592)
33. Engelmann H, Aderka D, Rubinstein M, et al. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989;264:11974-80. (Pubitemid 19185371)
34. Andus T, Gross V, Holstege A, et al. High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology 1992;16:749-55.
35. Cope AP, Aderka D, Doherty M, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-9.
36. Aderka D, Wysenbeek A, Engelmann H, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993;36:1111-20. (Pubitemid 23229288)
37. Denz H, Orth B, Weiss G, et al. Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss. Eur J Cancer 1993;29A:2232-5. (Pubitemid 24052998)
38. Ripley BJ, Fujimoto M, Serada S, et al. Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression. Int Immunol 2010;22:359-66.
39. Matsumoto A, Masuhara M, Mitsui K, et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997;89:3148-54.
40. Pezet A, Ferrag F, Kelly PA, et al. T yrosine docking sites of the rat prolactin receptor required for association and activation of stat5. J Biol Chem 1997;272:25043-50. (Pubitemid 27415685)
41. Ram PA, Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 1999;274:35553-61. (Pubitemid 129512851)